KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Invested Capital (2016 - 2026)

Eli Lilly filings provide 18 years of Return on Invested Capital readings, the most recent being 0.0% for Q1 2026.

  • On a quarterly basis, Return on Invested Capital fell 1.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 1.0% decrease, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Invested Capital hit 0.0% in Q1 2026 for Eli Lilly, up from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.09% in Q2 2025 to a low of 0.0% in Q4 2025.
  • Median Return on Invested Capital over the past 5 years was 0.01% (2023), compared with a mean of 0.01%.
  • The widest YoY moves for Return on Invested Capital: up 8bps in 2025, down -1bps in 2025.
  • Eli Lilly's Return on Invested Capital stood at 0.01% in 2022, then surged by 56bps to 0.01% in 2023, then increased by 7bps to 0.01% in 2024, then tumbled by -68bps to 0.0% in 2025, then rose by 9bps to 0.0% in 2026.
  • The last three reported values for Return on Invested Capital were 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025) per Business Quant data.